Low Intensity, Transcranial, Alternating Current Stimulation Reduces Migraine Attack Burden in a Home Application Set-Up: A Double-Blinded, Randomized Feasibility Study
- PMID: 33233400
- PMCID: PMC7700448
- DOI: 10.3390/brainsci10110888
Low Intensity, Transcranial, Alternating Current Stimulation Reduces Migraine Attack Burden in a Home Application Set-Up: A Double-Blinded, Randomized Feasibility Study
Abstract
Background: Low intensity, high-frequency transcranial alternating current stimulation (tACS) applied over the motor cortex decreases the amplitude of motor evoked potentials. This double-blind, placebo-controlled parallel group study aimed to test the efficacy of this method for acute management of migraines. Methods: The patients received either active (0.4 mA, 140 Hz) or sham stimulation for 15 min over the visual cortex with the number of terminated attacks two hours post-stimulation as the primary endpoint, as a home therapy option. They were advised to treat a maximum of five migraine attacks over the course of six weeks. Results: From forty patients, twenty-five completed the study, sixteen in the active and nine in the sham group with a total of 102 treated migraine attacks. The percentage of terminated migraine attacks not requiring acute rescue medication was significantly higher in the active (21.5%) than in the sham group (0%), and the perceived pain after active stimulation was significantly less for 2-4 h post-stimulation than after sham stimulation. Conclusion: tACS over the visual cortex has the potential to terminate migraine attacks. Nevertheless, the high drop-out rate due to compliance problems suggests that this method is impeded by its complexity and time-consuming setup.
Keywords: acute treatment; migraine; tACS; transcranial stimulation; visual cortex.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.Lancet Neurol. 2010 Apr;9(4):373-80. doi: 10.1016/S1474-4422(10)70054-5. Epub 2010 Mar 4. Lancet Neurol. 2010. PMID: 20206581 Clinical Trial.
-
Prophylactic treatment in menstrual migraine: A proof-of-concept study.J Neurol Sci. 2015 Jul 15;354(1-2):103-9. doi: 10.1016/j.jns.2015.05.009. Epub 2015 May 14. J Neurol Sci. 2015. PMID: 26003225 Clinical Trial.
-
Using High-Definition Transcranial Alternating Current Stimulation to Treat Patients with Fibromyalgia: A Randomized Double-Blinded Controlled Study.Life (Basel). 2022 Aug 31;12(9):1364. doi: 10.3390/life12091364. Life (Basel). 2022. PMID: 36143400 Free PMC article.
-
Transcranial direct current stimulation in the prophylactic treatment of migraine based on interictal visual cortex excitability abnormalities: A pilot randomized controlled trial.J Neurol Sci. 2015 Feb 15;349(1-2):33-9. doi: 10.1016/j.jns.2014.12.018. Epub 2014 Dec 18. J Neurol Sci. 2015. PMID: 25579414 Clinical Trial.
-
Effects of Non-invasive Brain Stimulation on Headache Intensity and Frequency of Headache Attacks in Patients With Migraine: A Systematic Review and Meta-Analysis.Headache. 2019 Oct;59(9):1436-1447. doi: 10.1111/head.13645. Epub 2019 Sep 18. Headache. 2019. PMID: 31535368
Cited by
-
Transcranial Electrical Stimulation Offers the Possibility of Improving Teamwork Among Military Pilots: A Review.Front Neurosci. 2022 Jul 13;16:931265. doi: 10.3389/fnins.2022.931265. eCollection 2022. Front Neurosci. 2022. PMID: 35911997 Free PMC article. Review.
-
Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.JAMA. 2021 Jun 15;325(23):2357-2369. doi: 10.1001/jama.2021.7939. JAMA. 2021. PMID: 34128998 Free PMC article.
-
Excitation-Inhibition Imbalance in Migraine: From Neurotransmitters to Brain Oscillations.Int J Mol Sci. 2023 Jun 13;24(12):10093. doi: 10.3390/ijms241210093. Int J Mol Sci. 2023. PMID: 37373244 Free PMC article. Review.
-
Remotely Monitored Home-Based Neuromodulation With Transcranial Alternating Current Stimulation (tACS) for Mal de Débarquement Syndrome.Front Neurol. 2021 Dec 9;12:755645. doi: 10.3389/fneur.2021.755645. eCollection 2021. Front Neurol. 2021. PMID: 34956048 Free PMC article.
-
Hallmarks of primary headache: part 1 - migraine.J Headache Pain. 2024 Oct 31;25(1):189. doi: 10.1186/s10194-024-01889-x. J Headache Pain. 2024. PMID: 39482575 Free PMC article. Review.
References
-
- Lipton R.B., Dodick D.W., Silberstein S.D., Saper J.R., Aurora S.K., Pearlman S.H., Fischell R.E., Ruppel P.L., Goadsby P.J. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: A randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9:373–380. doi: 10.1016/S1474-4422(10)70054-5. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources